Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Cristália Produtos Químicos Farmacêuticos Ltda.
Sponsor:
Information provided by (Responsible Party):
Cristália Produtos Químicos Farmacêuticos Ltda.
ClinicalTrials.gov Identifier:
NCT01308528
First received: March 1, 2011
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)